The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States
Open accessAbstract
The nuclear bile acid receptor FXR is critical for regulation of lipid and glucose metabolism. Here, we report that FXR is a target of SIRT1, a deacetylase that mediates nutritional and hormonal modulation of hepatic metabolism. Lysine 217 of FXR is the major acetylation site targeted by p300 and SIRT1. Acetylation of FXR increases its stability but inhibits heterodimerization with RXRalpha, DNA binding, and transactivation activity. Downregulation of hepatic SIRT1 increased FXR acetylation with deleterious metabolic outcomes. Surprisingly, in mouse models of metabolic disease, FXR interaction with SIRT1 and p300 was dramatically altered, FXR acetylation levels were elevated, and overexpression of SIRT1 or resveratrol treatment reduced acetylated FXR levels. Our data demonstrate that FXR acetylation is normally dynamically regulated by p300 and SIRT1 but is constitutively elevated in metabolic disease states. Small molecules that inhibit FXR acetylation by targeting SIRT1 or p300 may be promising therapeutic agents for metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been demonstrated that the gene encoding FMO3 is a direct FXR target gene, and FXR has been found to be a target of sirtuin 1 (SIRT1) in metabolic regulation (23, 34, 35).”
In the citing paper
“Moreover, RSV increased the expression and activity of FMO3 in the liver, corresponding with previously published results (34).”
In the citing paper
“It has been demonstrated that the gene encoding FMO3 is a direct FXR target gene, and FXR has been found to be a target of sirtuin 1 (SIRT1) in metabolic regulation (23, 34, 35).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,366
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 2×
“, 2006) and protection of intestines from intestinal bacteria growth (Inagaki et al., 2006).”
Background
Cited by
Sorted by citations
Items 201–300 of 330
Nuclear Receptor Coregulators in Metabolism and Disease
Giudici, M., Goñi, S., Fan, R., & Treuter, E. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_5 · Cited by 27
Mani, K. M., Javaheri, A., & Diwan, A. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180005 · Cited by 29
Ge, J. P., Li, G., Chen, Z., Xu, W., Lei, X., & Zhu, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23336 · Cited by 26
Streicher, W., Luedeke, M., Azoitei, A., Zengerling, F., Herweg, A., Genze, F., Schrader, M. G., Schrader, A. J., & Cronauer, M. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098566 · Cited by 28
MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH
Zarfeshani, A., Ngo, S., & Sheppard, A. M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4111938 · Cited by 26
The role of apolipoprotein A 5 in obesity and the metabolic syndrome
Zheng, X., Zhao, S., & Yan, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12005 · Cited by 26
Liu, C., Pan, Z., Wu, Z.-L., Tang, K., Zhong, Y., Chen, Y., Xiao, X., Guo, J., Duan, S., Cui, T., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.04.011 · Cited by 25
Ge, Y., Zhang, L., Chen, W., Sun, M., Liu, W., & Li, X. (2023) · Antioxidants · doi:10.3390/antiox12010121 · Cited by 26
Wan, S., Kuipers, F., Havinga, R., Ando, H., Vance, D. E., Jacobs, R. L., & van der Veen, J. N. (2019) · Hepatology Communications · doi:10.1002/hep4.1302 · Cited by 24
Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function
Han, C. Y., Kim, T. H., Koo, J. H., & Kim, S. G. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0812-y · Cited by 23
Inter-organ regulation of adipose tissue browning
Wang, S., & Yang, X. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2420-x · Cited by 23
Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice
Sun, H., Seok, S., Jung, H.-K., KEMPER, B. W., & Kemper, J. K. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101603 · Cited by 22
Self-citationRodríguez‐Ortigosa, C. M., Celay, J., Olivas, I., Juanarena, N., Arcelus, S., Uriarte, I., Marı́n, J. J. G., Avila, M. A., Medina, J. F., & Prìeto, J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.030 · Cited by 23
Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity
Pasquel, D., Dořičáková, A., Li, H., Kortagere, S., Krasowski, M. D., Biswas, A., Walton, W. G., Redinbo, M. R., Dvořák, Z., & Mani, S. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.01.006 · Cited by 22
Bile-ology: from bench to bedside
Jin, L., Fang, Z., Fan, M.-J., & Huang, W. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900158 · Cited by 22
Wang, Y., Yu, Y., Li, L., Zheng, M., Zhou, J., Gong, H., Feng, B., Wang, X., Meng, X., Cui, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40565-7 · Cited by 23
Zhou, M., Pei, B., Cai, P., Yi, C., Akanyibah, F. A., Lyu, C., & Mao, F. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04365-8 · Cited by 20
Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy
Nenkov, M., Shi, Y. H., Ma, Y., Gaßler, N., & Chen, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010006 · Cited by 23
Breaux, M., Lewis, K., Valanejad, L., Iakova, P. A., Chen, F., Mo, Q., Medrano, E. E., Timchenko, L., & Timchenko, N. A. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00421-15 · Cited by 20
Garzel, B., Zhang, L., Huang, S. M., & Wang, H. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666190709170256 · Cited by 21
The potential role of phenolic compounds on modulating gut microbiota in obesity
Yen, G., Cheng, H. T., Lin, L.-Y., Chen, S., & Hsu, C. L. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.1054 · Cited by 22
Molla, M. D., Dessie, G., Akalu, Y., & Ayelign, B. (2020) · International Journal of Hepatology · doi:10.1155/2020/2374615 · Cited by 20
Metabolism and chromatin dynamics in health and disease
Rodriguez, H., Rafehi, H., Bhave, M. R., & El‐Osta, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.004 · Cited by 18
Farnesoid X Receptor Agonists: What They Are and How They Might Be Used in Treating Liver Disease
Neuschwander‐Tetri, B. A. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0232-6 · Cited by 18
p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair
Lai, K. K. Y., Hu, X., Chosa, K., Nguyen, C., Lin, D. P., Lai, K., Kato, N., Higuchi, Y., Highlander, S. K., Melendez, E., et al. (2021) · Cancers · doi:10.3390/cancers13061288 · Cited by 17
Inflammatory liver diseases and susceptibility to sepsis
Lü, H. (2024) · Clinical Science · doi:10.1042/cs20230522 · Cited by 18
Hepatic PPARα Is Destabilized by SIRT1 Deacetylase in Undernourished Male Mice
Suh, J. H., Kim, K. H., Conner, M. E., Moore, D. D., & Preidis, G. A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.831879 · Cited by 16
Merk, D., Steinhilber, D., & Schubert‐Zsilavecz, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.860129 · Cited by 16
When Food Meets Man: the Contribution of Epigenetics to Health
Fabiani, E. D., Mitro, N., Gilardi, F., Galmozzi, A., Caruso, D., & Crestani, M. (2010) · Nutrients · doi:10.3390/nu2050551 · Cited by 15
Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility
Anyetei‐Anum, C. S., Evans, R. M., Back, A. M., Roggero, V. R., & Allison, L. A. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110509 · Cited by 16
Lactylation-mediated miRNA regulation in cancer therapy resistance
Shou, Y., Liu, R., Xiong, H., Chen, X., Huang, L., Huang, R., Sheng, H., Zhang, H., Lu, Y., & Guo, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06959-5 · Cited by 15
Metformin impairs systemic bile acid homeostasis through regulating SIRT1 protein levels
Chen, Q., Yang, X., Zhang, H., Kong, X., Yao, L., Cui, X., Zou, Y., Fang, F., Yang, J., & Chang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.10.020 · Cited by 15
Association of FXR gene variants with cholelithiasis
Hirobe-Jahn, S., Harsch, S., Renner, O., Richter, D., Müller, O. J., & Stange, E. F. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.002 · Cited by 15
Ghanem, C. I., & Manautou, J. E. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000450 · Cited by 14
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2020) · Nutrients · doi:10.3390/nu12103108 · Cited by 14
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
Ma, C., Xiang, J., Huang, G., Zhao, Y., Wang, X., Wu, H., Jiang, K., Liang, Z., Kang, L., Yang, G., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.785403 · Cited by 14
Suppression of SIRT1/FXR signaling pathway contributes to oleanolic acid-induced liver injury
Liao, S., Fu, X., Huang, J., Wang, Y., Lu, Y., & Zhou, S. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116509 · Cited by 14
MicroRNA-126 Overexpression Inhibits Proliferation and Invasion in Osteosarcoma Cells
Wang, S., Wang, X., Guo, Q., Wang, G., Han, X., Xiao, L., Shi, Z.-W., & He, W. (2015) · Technology in Cancer Research & Treatment · doi:10.1177/1533034615601563 · Cited by 13
Disentangling Organ‐Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism
Li, T., Fu, C., Tang, Z., Li, C., Hua, D., Liu, B., Tao, Z., Yang, J., Zhang, L., Cheng, T., et al. (2025) · Liver International · doi:10.1111/liv.70027 · Cited by 12
Phytochemical regulation of Fyn and AMPK signaling circuitry
Lee, C. G., Koo, J. H., & Kim, S. G. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0611-x · Cited by 12
Kim, Y., Qi, M., Dong, X., Seok, S., Sun, H., KEMPER, B. W., Fu, T., & Kemper, J. K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104946 · Cited by 11
Self-citationUnravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review
Gioukaki, C., Georgiou, A., Gkaralea, L. E., Κroupis, C., Lazaris, A. C., Alamanis, C., & Thomopoulou, G. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411299 · Cited by 11
Appelman, M. D., Robin, M. J. D., Vogels, E. W. M., Wolzak, C., Vos, W. G., Vos, H. R., van Es, R. M., Burgering, B. M. T., & van de Graaf, S. F. J. (2020) · Cells · doi:10.3390/cells9040986 · Cited by 11
Bai, X., Liu, Z., Li, X., Sun, R., & Yu, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07037-6 · Cited by 10
CBP/p300, a promising therapeutic target for prostate cancer
Xu, H., Hou, Y., Zhao, Z., Zhang, J., Li, P., Cao, Y., Nie, X., & Hou, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07053-6 · Cited by 13
In Vivo Analysis of miR-34a Regulated Glucose Metabolism Related Genes in Megalobrama amblycephala
Miao, L., Lin, Y., Huang, X., Pan, W.-J., Zhou, Q., Liu, B., Ren, M., Ge, X., & Pan, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082417 · Cited by 10
Transcription Factors Potentially Involved in Regulation of Cytochrome P450 Gene Expression
Czekaj, P., & Skowronek, R. (2012) · InTech eBooks · doi:10.5772/27817 · Cited by 10
How to modulate FXR activity to treat the Metabolic Syndrome
Prawitt, J., Caron, S., & Staels, B. (2009) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.05.002 · Cited by 10
Choudhury, D., Levi, M., & Tuncel, M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10023-5 · Cited by 10
Lee, D., Martinez, B., Crocker, D. E., & Ortiz, R. M. (2017) · Physiological Reports · doi:10.14814/phy2.13114 · Cited by 10
Hwang, J., Choi, H., Kim, S. H., Chung, S., Hur, H. J., Park, J. H., & Chung, M. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3912 · Cited by 10
Bayoude, A., Zhang, J., Shen, Y., Tilyek, A., & Chai, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119400 · Cited by 9
Xu, J., Xue, Q., Xiong, A., Chen, Y., Wang, X., Yan, X., Ruan, D., Zhang, Y., Wang, Z., Ding, L., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01077-2 · Cited by 9
Venhorst, J., Hanemaaijer, R., Dulos, R., Caspers, M. P. M., Toet, K. H., Attema, J., de Ruiter, C., Kalkman, G. J., Rankouhi, T. R., de Jong, J. C. B. C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1442752 · Cited by 8
FXR Friend-ChIPs in the Enterohepatic System
Meadows, V., Yang, Z., Basaly, V., & Guo, G. L. (2023) · Seminars in Liver Disease · doi:10.1055/a-2128-5538 · Cited by 8
Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells
Lee, Y., Lee, E., You, Y., Ahn, Y., Song, K., Kim, J.-W., & Ko, S. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1806285 · Cited by 9
Analysis of Nuclear Receptor Acetylation
Wang, C., Powell, M. J., Tian, L., & Pestell, R. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-243-4_11 · Cited by 8
FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity
Panzitt, K., Jungwirth, E., Vosko, L. E., Madreiter‐Sokolowski, C. T., Madl, T., Tawfik, I., Habisch, H., Krstić, J., Prokesch, A., Karitnig, R., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn4558 · Cited by 7
Zhao, M., Li, G., & Zhao, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1477619 · Cited by 7
Yang, H., Sun, Y., Zhang, J., Xu, S., Tang, L., Gong, J., Fang, H., Lin, Y., Ren, J., & Su, D. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105679 · Cited by 6
Kalantary‐Charvadeh, A., Ahmad, S. N. S., Aslani, S., Beyrami, M., & Abbasi, M. M. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23564 · Cited by 7
Sun, A., Luo, Y., Backos, D. S., Xu, S., Balasubramaniyan, N., Reigan, P., & Suchy, F. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084772 · Cited by 7
Chen, C., Liu, X., Wang, J., Wen, X., Zhao, H., Chen, G., & Wu, K. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.03.012 · Cited by 6
Hejazi, K., Hosseini, S. R. A., Fathi, M., & Ziaaldini, M. M. (2020) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums.101849 · Cited by 5
The decreased SIRT1 level may account for the lipid profile in chronic kidney disease
Chen, G., & Li, X. (2019) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-019-0101-2 · Cited by 5
Role of nuclear receptors in hepatitis B and C infections
André, P., Ramière, C., Scholtès, C., Curtil, C., & Lotteau, V. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.01.001 · Cited by 4
Role of microRNAs in Osteosarcopenic Obesity/Adiposity: A Scoping Review
Braile, M., Braile, A., Greggi, C., Visconti, V. V., Toro, G., Trotta, M. C., Conza, G., & Tarantino, U. (2025) · Cells · doi:10.3390/cells14110802 · Cited by 3
van der Veen, S. W., Dijkstra, J. J., Willemsen, E. C. L., Houtman, R., Milona, A., Marchet, N., Spit, M., Hollman, D. A. A., Zwartkruis, F. J. T., Vermeulen, M., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1214 · Cited by 3
Han, M., Cheng, Y., Wang, W., Ye, S., Kong, L., Zhang, Y., & Zhang, H. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117200 · Cited by 3
Bielach-Bazyluk, A., Czajkowska, K., Koc‐Żórawska, E., Hryszko, T., & Zbroch, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189033 · Cited by 3
Porez, G., Prawitt, J., Gross, B. S., & Staels, B. (2012) · Cited by 3
SIRT1 in Metabolic Health and Disease
Boutant, M., & Cantó, C. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_4 · Cited by 3
Nuclear Receptors and Lipid Sensing
Thorne, J. L., & Cioccoloni, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_5 · Cited by 3
Garcia, M., Holota, H., Haze, A. D., Saru, J., Sanchez, P., Battistelli, E., Thirouard, L., Monrose, M., Benoit, G., Volle, D. H., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108022 · Cited by 2
Mi, Q.-R., Wu, C.-Q., Lv, C.-G., Zhao, K.-E., Liu, Z.-F., Xu, P., & Li, L. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01726-0 · Cited by 2
Zhao, S., Zhang, J., Mi, Y., Quan, B., Hu, Z., Zhong, X., Xu, Y., Cai, S., Li, X., Wei, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71403-1 · Cited by 2
The Importance of Metabolites in Modulating Insulin Sensitivity
Meiliana, A., Dewi, N. M., & Wijaya, A. (2022) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v14i3.1872 · Cited by 1
Acetyl-CoA and acetylation in biology and disease
Puglielli, L., Rigby, M. J., & Fernandez-Fuente, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00009-7 · Cited by 2
Manocchio, F., Morales, D., Navarro‐Masip, È., Aragonès, G., Torres‐Fuentes, C., Bravo, F. I., & Muguerza, B. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70126 · Cited by 1
Sirtuins and metabolic regulation: food and supplementation
Santos, S. H. S., Guimarães, V. H. D., Oliveira, J. R., & de Rezende, L. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00003-6 · Cited by 3
The Emerging Role of Sirtuin 1,-3 and -4 in Glucose and Lipid Metabolism and in Diabetes Mellitus
Akbaş, E. M. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-018 · Cited by 3
Le silence parlant de la sirtuine 1 dans la stéatose et le cancer du foie
Gilgenkrantz, H., & Perret, C. (2012) · médecine/sciences · doi:10.1051/medsci/2012283014 · Cited by 2
Hepatotoxicity and the Circadian Clock
de Wit, A. S., Nijman, R., Destici, E., Chaves, I., & van der Horst, G. T. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397862-2.00013-9 · Cited by 2
Protein Lysine Acylation: Abundance, Dynamics and Function
Pougovkina, O., & de Boer, V. C. J. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_3 · Cited by 2
Crosstalk between microRNA and inflammation; critical regulator of diabetes
El‐Sehrawy, A. A. M. A., Mohammed, M. H., Salahdin, O. D., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Joshi, K. K., Kadim, A. S., & KADHIM, A. J. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114507 · Cited by 1
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
Lefèbvre, P., & Staels, B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.020 · Cited by 1
THE ROLE OF PXR AND IKKβ SIGNALING IN CARDIOMETABOLIC DISEASE
Helsley, R. N. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.040 · Cited by 1
DiStefano, J. K., & Wu, X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823931-5.00006-2 · Cited by 1
Metabolic Rhythm of Hepatic Lipogenesis: Regulation and Roles in Metabolism
Jacobi, D., Cho, H., Alexander, R., & Lee, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_11 · Cited by 1
Transactivation versus transrepression in FXR: lessons learned from other Nuclear Receptors
Hollman, D. A. A. (2011) · Utrecht University Repository (Utrecht University)
Manley, S. (2014) · KU ScholarWorks (The University of Kansas)
Metabolic and cellular effects of calorie restriction and whey proteins in experimental obesity
Kurki, E. (2013) · Työväentutkimus Vuosikirja
Murphy, C. A. (2010) · ScholarlyCommons (University of Pennsylvania)
Role of SIRT1 in Vascular Complications of Diabetes
Mortuza, R. (2014) · Scholarship@Western (Western University)
The role of the farnesoid X receptor in metabolic control
Stroeve, J. H. M. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology)
REGULATION OF DRUG METABOLISM AND INFLAMMATION BY PREGNANE X RECEPTOR
Xu, C. (2011) · KU ScholarWorks (The University of Kansas)
Gene selective regulation by hepatic Farnesoid x receptor (fxr) in health and disease
Lee, J. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Zhan, L. (2014) · KU ScholarWorks (The University of Kansas)
Alzaïd, F., Jakobsson, T., Treuter, E., & Venteclef, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_116-1
Metadata
- Authors
- Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S.-Y., Chiang, C.-M., & Veenstra, T. D.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Frederick National Laboratory for Cancer Research (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Kemper, Jongsook Kim
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 10
- Issue
- 5
- Pages
- 392-404
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2785075
- OpenAlex
- W1983620925
- Cited by
- 332
- References
- 39
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 10 · 2023: 15 · 2022: 17 · 2021: 16 · 2020: 22 · 2019: 20 · 2018: 23 · 2017: 22 · 2016: 15 · 2015: 18 · 2014: 29 · 2013: 29 · 2012: 30
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DigitalCommons-Cedarville (Cedarville University) (submittedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400, N01-CO-012400, CA103867, R01CA103867, R01CA124760, CA124760)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK062777, R01DK080032, DK062777, R56DK062777, DK80032)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- farnesoid X receptor, protein acetylation, P300, SIRT1, receptor stability, DNA binding, transcriptional activation, hepatic metabolism, metabolic disorders, resveratrol, small molecule drugs
- MeSH terms
- Resveratrol, Receptor, Farnesoid X-Activated, p300-CBP-Associated Factor, Acetylation, Animals, Disease Models, Animal, Histone Deacetylases, Liver, Liver Diseases, Male, Stilbenes, Transcription Factors, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, Receptors, Cytoplasmic and Nuclear, Dimerization, RNA, Small Interfering, Retinoid X Receptor alpha, p300-CBP Transcription Factors, Mice, Protein Stability, Sirtuin 1, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review